Key regions: United Kingdom, Canada, Japan, Europe, China
Greece, a country known for its ancient history and beautiful beaches, is also a significant market for dermatological drugs.
Customer preferences: Greek consumers have shown a preference for dermatological drugs that are affordable and effective. With the rise of social media influencers and beauty bloggers, consumers are also becoming more aware of the importance of skincare and are willing to invest in high-quality products.
Trends in the market: The Greek dermatological drugs market has been growing steadily over the past few years due to an increase in skin-related diseases and disorders. Acne, eczema, and psoriasis are some of the most common skin conditions in Greece, leading to a higher demand for dermatological drugs. The market has seen a rise in the demand for natural and organic products, as consumers become more conscious of the ingredients in their skincare products. Greek companies are also focusing on developing innovative products to cater to this growing demand.
Local special circumstances: Greece has a warm and sunny climate, leading to a higher incidence of sun-related skin damage. As a result, there is a greater demand for dermatological drugs that provide protection against the harmful effects of the sun. Additionally, the country's aging population has contributed to the growth of the market, with a rise in demand for anti-aging products.
Underlying macroeconomic factors: The Greek economy has been recovering slowly from the financial crisis of 2008, leading to a rise in disposable income and consumer spending. This has contributed to the growth of the dermatological drugs market, as consumers are able to afford more expensive skincare products. The government's efforts to improve the healthcare system have also led to an increase in the availability of dermatological drugs, further driving the growth of the market.In conclusion, the Greek dermatological drugs market is growing steadily due to an increase in skin-related diseases and disorders, consumer awareness of skincare, and the availability of innovative products. The warm climate, aging population, and recovering economy are also contributing factors to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
